MicroBase Technology Corp.

TPEX:3184 Stock Report

Market Cap: NT$999.4m

MicroBase Technology Past Earnings Performance

Past criteria checks 3/6

MicroBase Technology has been growing earnings at an average annual rate of 26.7%, while the Medical Equipment industry saw earnings growing at 11.4% annually. Revenues have been declining at an average rate of 9% per year. MicroBase Technology's return on equity is 4.5%, and it has net margins of 12.5%.

Key information

26.7%

Earnings growth rate

31.2%

EPS growth rate

Medical Equipment Industry Growth11.5%
Revenue growth rate-9.0%
Return on equity4.5%
Net Margin12.5%
Last Earnings Update30 Jun 2023

Recent past performance updates

Recent updates

Is MicroBase Technology (GTSM:3184) Using Debt In A Risky Way?

Apr 11
Is MicroBase Technology (GTSM:3184) Using Debt In A Risky Way?

Is MicroBase Technology (GTSM:3184) Using Too Much Debt?

Dec 01
Is MicroBase Technology (GTSM:3184) Using Too Much Debt?

Revenue & Expenses Breakdown
Beta

How MicroBase Technology makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TPEX:3184 Revenue, expenses and earnings (TWD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 23190245121
31 Mar 23186155122
31 Dec 2218265223
30 Sep 22183-125430
30 Jun 22184-315537
31 Mar 22199-345843
31 Dec 21213-376150
30 Sep 21226-456655
30 Jun 21239-527160
31 Mar 21244-637669
31 Dec 20250-748077
30 Sep 20261-628277
30 Jun 20273-518477
31 Mar 20269-508674
31 Dec 19265-498771
30 Sep 19297-178872
30 Jun 19329158972
31 Mar 19326-18773
31 Dec 18324-188574
30 Sep 18244-728076
30 Jun 18165-1267678
31 Mar 18150-1227475
31 Dec 17136-1187272
30 Sep 17137-1377370
30 Jun 17139-1567467
31 Mar 17125-1597465
31 Dec 16111-1627463
30 Sep 16108-1367058
30 Jun 16106-1116652
31 Mar 16106-976347
31 Dec 15106-836042
30 Sep 15104-1106039
30 Jun 15102-1375935
31 Mar 1597-1495736
31 Dec 1491-1625536
30 Sep 1496-1275334
30 Jun 14101-925133
31 Mar 14181-375531
31 Dec 13261186030
30 Sep 13360826530
30 Jun 134591467129
31 Mar 134081096630

Quality Earnings: 3184 has high quality earnings.

Growing Profit Margin: 3184 became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 3184 has become profitable over the past 5 years, growing earnings by 26.7% per year.

Accelerating Growth: 3184 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 3184 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-18.3%).


Return on Equity

High ROE: 3184's Return on Equity (4.5%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.